- Home
- TCMD vs LXEO Comparison
TCMD vs LXEO Comparison
Compare TCMD & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCMD
- LXEO
- Stock Information
- Founded
- TCMD 1995
- LXEO 2017
- Country
- TCMD United States
- LXEO United States
- Employees
- TCMD N/A
- LXEO N/A
- Industry
- TCMD Medical/Dental Instruments
- LXEO
- Sector
- TCMD Health Care
- LXEO
- Exchange
- TCMD Nasdaq
- LXEO Nasdaq
- Market Cap
- TCMD 378.7M
- LXEO 314.1M
- IPO Year
- TCMD 2016
- LXEO 2023
- Fundamental
- Price
- TCMD $17.85
- LXEO $6.47
- Analyst Decision
- TCMD Hold
- LXEO Strong Buy
- Analyst Count
- TCMD 1
- LXEO 7
- Target Price
- TCMD N/A
- LXEO $22.71
- AVG Volume (30 Days)
- TCMD 310.3K
- LXEO 621.5K
- Earning Date
- TCMD 11-04-2024
- LXEO 11-13-2024
- Dividend Yield
- TCMD N/A
- LXEO N/A
- EPS Growth
- TCMD N/A
- LXEO N/A
- EPS
- TCMD 0.65
- LXEO N/A
- Revenue
- TCMD $285,051,000.00
- LXEO N/A
- Revenue This Year
- TCMD $8.83
- LXEO N/A
- Revenue Next Year
- TCMD $9.86
- LXEO N/A
- P/E Ratio
- TCMD $27.63
- LXEO N/A
- Revenue Growth
- TCMD 5.31
- LXEO N/A
- 52 Week Low
- TCMD $11.12
- LXEO $5.77
- 52 Week High
- TCMD $17.90
- LXEO $22.33
- Technical
- Relative Strength Index (RSI)
- TCMD 71.41
- LXEO 34.49
- Support Level
- TCMD $15.22
- LXEO $5.77
- Resistance Level
- TCMD $16.20
- LXEO $11.72
- Average True Range (ATR)
- TCMD 0.84
- LXEO 0.86
- MACD
- TCMD 0.16
- LXEO -0.13
- Stochastic Oscillator
- TCMD 99.01
- LXEO 11.76
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.